genome analysis
Sophia Genetics Q2 Revenue Grows 72 Percent
In its first quarterly report as a public company, Sophia reported a net loss of $18.4 million, in part due to higher expenses related to its July IPO.
Sophia Genetics Raises $234M in IPO, Eyes Additional Partnerships
The stock opened at $18 per share, valuing the Switzerland- and Boston-based bioinformatics company at $1.14 billion.
Sophia Genetics Increases IPO Target to $221M
The company will now offer 13 million common shares at $17 to $19 per share, raising its proceeds target from the previously announced $100 million.
NantHealth Q1 Revenues Decline 11 Percent
NantHealth reported a net loss of $15.4 million during the quarter, as sequencing and molecular analysis revenues fell to just $3,000.
NantHealth Q4 Revenues Flat From Year Ago
The firm posted total software-related revenues of $18.6 million, up 1 percent from $18.4 million in Q4 2019.
Nov 5, 2020
NantHealth Q3 Revenues Tick Up Slightly
Aug 6, 2020
NantHealth Q2 Revenues Decline 12 Percent
Apr 30, 2019
Congenica Raises £13.3M in Series B Add-On
Mar 27, 2018